Delivery Order SPE2DB22D9112-SPE2DB23FE6TY
Award Date 6/28/23
Potential Completion Date 7/20/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $38,685 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes for use by the Department of Defense. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September and October 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the U.S. military and this order is likely supporting immunology programs...
- <p>The Defense Logistics Agency (DOD) awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between June 26 and July 18, 2023. DLA facilitates supply chain management for the Department of Defense and this order is likely associated with the agency's medical materiel procurement programs. No subcontractors or set aside designations were indicated.</p>
- The Defense Logistics Agency awarded a $7,737 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes for use by the Department of Defense. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between August 2nd and August 23rd, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the DoD, procuring all manner of medical supplies and equipment to...
- <p>The Defense Logistics Agency (DOD) awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 MG/ML syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between May 23 and June 14, 2023. DLA facilitates supply chain management for the Department of Defense and this order is likely associated with the agency's medical materiel procurement programs. No subcontractors or set aside designations were indicated.</p>
- The Defense Logistics Agency (DOD) awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between June 29 and July 21, 2023. DLA facilitates supply chain management for the Department of Defense and this order is likely associated with DLA's Prime Vendor program to support medical treatment for military personnel, veterans, and their families. No set aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $11,605.50 to DMS Pharmaceutical Group Inc. to supply Xolair 75 MG/0.5 ML syringes. The firm fixed price order is for the delivery of 0.5mL syringes of Xolair to a location in Park Ridge, Illinois. Performance will take place between August 1st and August 22nd, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This...
- The Defense Logistics Agency Troop Support Medical awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes. The firm fixed price order is being fulfilled under the prime contractor's agreement with the Defense Logistics Agency. Performance will take place in Park Ridge, Illinois over a three week period concluding in late August. No subcontractors or set aside designations were indicated. The delivery order supports the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents to DMS Pharmaceutical Group Incorporated. The order is for Xolair 150 mg/ml syringes to be delivered to a location in Park Ridge, Illinois by March 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for the allergy medication Xolair supports the Agency's mission to provide medical...
- The Defense Logistics Agency awarded a $2,321.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4562280330 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between September 20 and October 12, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring medical supplies and pharmaceuticals to support military treatment facilities and readiness programs. No...
- The Defense Logistics Agency Troop Support Medical awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September 25 and October 17, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports Department of Defense health care programs through its medical supply chain and logistics management...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB23FE6TYDelivery Order
The Defense Logistics Agency awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes for use by the Department of Defense. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between June 28 and July 20, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the U.S. military and this order is likely supporting treatment programs for conditions such as allergic asthma where Xolair is commonly used.
Generated 12/23/23, 12:28 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/28/23 |